Hydroxychloroquine for COVID-19: a single center, retrospective cohort study
Introduction: The outbreak of coronavirus disease (COVID-19) in December 2019 called for a rapid solution, leading to repurposing of existing drugs. Due to its immunomodulatory effect and antiviral properties, hydroxychloroquine (HCQ) has been used in early 2020 for treatment of COVID-19 patients....
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Faculty of Medicine and Health Sciences, University Putra Malaysia
2022
|
| Online Access: | http://psasir.upm.edu.my/id/eprint/101756/1/2023032211275502_MJMHS_0551.pdf |